Baldur is a Global Group Head in Early Development Analytics at Novartis, leading a team that provides biostatistics support in non-clinical, digital, and exploratory biomarkers. Previous roles at Novartis include project statistician in early clinical development and consultant in the Advanced Methodology and Data Science team. Baldur has been involved in several methodological initiatives, focusing on topics such as visualization, dose finding, historical data, and causal inference. Baldur holds a PhD in statistics from Cornell University.